INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 34 filers reported holding INMUNE BIO INC in Q2 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $16,004 | -45.4% | 2,364 | -26.8% | 0.00% | – |
Q2 2023 | $29,319 | +34.2% | 3,229 | -4.5% | 0.00% | – |
Q1 2023 | $21,841 | -54.7% | 3,381 | -55.5% | 0.00% | – |
Q4 2022 | $48,203 | -38.2% | 7,603 | -40.0% | 0.00% | – |
Q3 2022 | $78,000 | -35.5% | 12,678 | -7.0% | 0.00% | – |
Q2 2022 | $121,000 | +0.8% | 13,627 | -4.1% | 0.00% | – |
Q1 2022 | $120,000 | +1.7% | 14,216 | +23.5% | 0.00% | – |
Q4 2021 | $118,000 | +131.4% | 11,509 | +338.1% | 0.00% | – |
Q3 2021 | $51,000 | +5000.0% | 2,627 | +4951.9% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 52 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 52 | +30.0% | 0.00% | – |
Q4 2020 | $1,000 | – | 40 | 0.0% | 0.00% | – |
Q3 2020 | $0 | – | 40 | +73.9% | 0.00% | – |
Q2 2020 | $0 | – | 23 | +4.5% | 0.00% | – |
Q1 2020 | $0 | – | 22 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 230,500 | $2,351,000 | 1.70% |
Fermata Advisors, LLC | 17,955 | $183,000 | 0.07% |
Virtu Financial LLC | 24,364 | $249,000 | 0.02% |
YorkBridge Wealth Partners, LLC | 10,369 | $106,000 | 0.02% |
Jump Financial, LLC | 21,100 | $215,000 | 0.01% |
Financial Advocates Investment Management | 15,167 | $155,000 | 0.01% |
FNY Investment Advisers, LLC | 1,100 | $11,000 | 0.01% |
Janney Montgomery Scott LLC | 113,914 | $1,162,000 | 0.01% |
Walleye Capital LLC | 17,127 | $175,000 | 0.01% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 12,473 | $127,000 | 0.00% |